328 related articles for article (PubMed ID: 18647617)
1. Biosensor discovery of thyroxine transport disrupting chemicals.
Marchesini GR; Meimaridou A; Haasnoot W; Meulenberg E; Albertus F; Mizuguchi M; Takeuchi M; Irth H; Murk AJ
Toxicol Appl Pharmacol; 2008 Oct; 232(1):150-60. PubMed ID: 18647617
[TBL] [Abstract][Full Text] [Related]
2. Biosensor recognition of thyroid-disrupting chemicals using transport proteins.
Marchesini GR; Meulenberg E; Haasnoot W; Mizuguchi M; Irth H
Anal Chem; 2006 Feb; 78(4):1107-14. PubMed ID: 16478101
[TBL] [Abstract][Full Text] [Related]
3. Spreeta-based biosensor assays for endocrine disruptors.
Marchesini GR; Koopal K; Meulenberg E; Haasnoot W; Irth H
Biosens Bioelectron; 2007 Apr; 22(9-10):1908-15. PubMed ID: 16971108
[TBL] [Abstract][Full Text] [Related]
4. Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins.
Cao J; Lin Y; Guo LH; Zhang AQ; Wei Y; Yang Y
Toxicology; 2010 Nov; 277(1-3):20-8. PubMed ID: 20804816
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe.
Ren XM; Guo LH
Environ Sci Technol; 2012 Apr; 46(8):4633-40. PubMed ID: 22482873
[TBL] [Abstract][Full Text] [Related]
6. Surface plasmon resonance assay of inhibition by pharmaceuticals for thyroxine hormone binging to transport proteins.
Kinouchi H; Matsuyama K; Kitagawa H; Kamimori H
Anal Biochem; 2016 Jan; 492():43-8. PubMed ID: 26384643
[TBL] [Abstract][Full Text] [Related]
7. Blood plasma sample preparation method for the assessment of thyroid hormone-disrupting potency in effect-directed analysis.
Simon E; Bytingsvik J; Jonker W; Leonards PE; de Boer J; Jenssen BM; Lie E; Aars J; Hamers T; Lamoree MH
Environ Sci Technol; 2011 Sep; 45(18):7936-44. PubMed ID: 21842831
[TBL] [Abstract][Full Text] [Related]
8. Effects on thyroid hormone metabolism and depletion of lung vitamin A in rats by airborne particulate matter.
Heussen GA; Schefferlie GJ; Talsma MJ; van Til H; Dohmen MJ; Brouwer A; Alink GM
J Toxicol Environ Health; 1993 Apr; 38(4):419-34. PubMed ID: 8478982
[TBL] [Abstract][Full Text] [Related]
9. Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin.
Munro SL; Lim CF; Hall JG; Barlow JW; Craik DJ; Topliss DJ; Stockigt JR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1141-7. PubMed ID: 2498384
[TBL] [Abstract][Full Text] [Related]
10. Hydroxylated polybrominated diphenyl ethers and bisphenol A in pregnant women and their matching fetuses: placental transfer and potential risks.
Wan Y; Choi K; Kim S; Ji K; Chang H; Wiseman S; Jones PD; Khim JS; Park S; Park J; Lam MH; Giesy JP
Environ Sci Technol; 2010 Jul; 44(13):5233-9. PubMed ID: 20509646
[TBL] [Abstract][Full Text] [Related]
11. Assessing the role of ortho-substitution on polychlorinated biphenyl binding to transthyretin, a thyroxine transport protein.
Chauhan KR; Kodavanti PR; McKinney JD
Toxicol Appl Pharmacol; 2000 Jan; 162(1):10-21. PubMed ID: 10631123
[TBL] [Abstract][Full Text] [Related]
12. Recombinant transthyretin purification and competitive binding with organohalogen compounds in two gull species (Larus argentatus and Larus hyperboreus).
Ucán-Marín F; Arukwe A; Mortensen A; Gabrielsen GW; Fox GA; Letcher RJ
Toxicol Sci; 2009 Feb; 107(2):440-50. PubMed ID: 19033396
[TBL] [Abstract][Full Text] [Related]
13. New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors.
Montaño M; Cocco E; Guignard C; Marsh G; Hoffmann L; Bergman A; Gutleb AC; Murk AJ
Toxicol Sci; 2012 Nov; 130(1):94-105. PubMed ID: 22859314
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2',4,4'-tetrabromodiphenyl ether (BDE-47).
Hamers T; Kamstra JH; Sonneveld E; Murk AJ; Visser TJ; Van Velzen MJ; Brouwer A; Bergman A
Mol Nutr Food Res; 2008 Feb; 52(2):284-98. PubMed ID: 18161906
[TBL] [Abstract][Full Text] [Related]
15. Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity.
Purkey HE; Palaninathan SK; Kent KC; Smith C; Safe SH; Sacchettini JC; Kelly JW
Chem Biol; 2004 Dec; 11(12):1719-28. PubMed ID: 15610856
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin.
Cheek AO; Kow K; Chen J; McLachlan JA
Environ Health Perspect; 1999 Apr; 107(4):273-8. PubMed ID: 10090705
[TBL] [Abstract][Full Text] [Related]
17. Detection of thyroid hormone receptor disruptors by a novel stable in vitro reporter gene assay.
Freitas J; Cano P; Craig-Veit C; Goodson ML; Furlow JD; Murk AJ
Toxicol In Vitro; 2011 Feb; 25(1):257-66. PubMed ID: 20732405
[TBL] [Abstract][Full Text] [Related]
18. Structural studies on the endocrine-disrupting role of polybrominated diphenyl ethers (PBDEs) in thyroid diseases.
Sheikh IA; Beg MA
Environ Sci Pollut Res Int; 2020 Oct; 27(30):37866-37876. PubMed ID: 32613508
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons.
Schuur AG; Legger FF; van Meeteren ME; Moonen MJ; van Leeuwen-Bol I; Bergman A; Visser TJ; Brouwer A
Chem Res Toxicol; 1998 Sep; 11(9):1075-81. PubMed ID: 9760282
[TBL] [Abstract][Full Text] [Related]
20. Change in structure of the N-terminal region of transthyretin produces change in affinity of transthyretin to T4 and T3.
Prapunpoj P; Leelawatwatana L; Schreiber G; Richardson SJ
FEBS J; 2006 Sep; 273(17):4013-23. PubMed ID: 16879610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
